Best Investment Stock : Target we can see 500% Upside from here.

Gujarat Themis Biosyn is principally engaged in the business pertaining to manufacturing of pharmaceuticals and medicinal chemicals.
Pioneer in manufacturing Rifampicin
The Company entered into Technical & Financial collaboration with Yuhan Corporation, South Korea. With Yuhan’s know-how, GTBL became India’s first Company to start commercial production of Anti-tuberculosis drug Rifampicin.

Product Portfolio
The Co. is presently manufacturing Rifamycin S, which is an intermediate for manufacturing the drug Rifampicin, and Rifamycin O, which is an intermediate for manufacturing the drug Rifaximin. The production capacity of Rifamycin S is 10,000 kgs/month and that of Rifamycin O is 6,000 kgs/month.

Change in Business Model
The Company which was doing Job Work for other pharma companies with fixed contracted price changed its business model in FY20 from contract manufacturing to manufacturing and sales model. This seems to have changed the margin profile from ~18% to ~30%.

Manufacturing Facility
The Co. has a state-of-the-art manufacturing facility at Vapi, Gujarat.


Market Cap
₹ 943 Cr.
Current Price
₹ 649
High / Low
₹ 921 / 362
Stock P/E
16.8
Book Value
₹ 92.2
Dividend Yield
0.93 %
ROCE
66.8 %
ROE
50.4 %
Face Value
₹ 5.00
Debt
₹ 1.23 Cr.
EPS
₹ 38.6
PEG Ratio
0.29
Promoter holding
75.0 %
Intrinsic Value
₹ 621
Pledged percentage
0.00 %
EVEBITDA
11.8

Company has reduced debt.
Company is almost debt free.
Company is expected to give good quarter
Company has delivered good profit growth of 58.4% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 56.0%

Well i have done my analysis and i found it best investment idea for now. I have written everything on chart and the discription. Please take trade accordingly.

guy's i really do hard work to get these analysis. Please support me by like and follow.
Thankyou.